Signet-Ring Cell Carcinoma of the Distal Common Bile Duct: Report of a Case

Abstract

Interestingly, all four patients were Asians, but their age and follow-up data were variable. Because this type of variant is extremely rare in sites other than the stomach, SRCC of gastric origin should be excluded, once it is found in another site. In the present case, gastroduo- denal fiberscopy revealed no mucosal lesion in the stomach, du- odenum, or peri-ampullary region. [...]it is unlikely that the tumor is a metastatic lesion.

Signet-ring cell carcinoma (SRCC) of the extrahepatic bile duct is a histologically distinct entity classified by the World Health Organization, in which cells containing intracytoplasmic mucin displacing the nucleus predominate.1 SRCC of the gas- trointestinal tract is most commonly found in the stomach, and the impact of this histology on the prognosis is controversial.2,3

Well to moderately differentiated adenocarcinoma is the most common histologic type and complete resection is the only po- tentially curative therapy for distal bile duct cancer.4 However SRCC of extrahepatic bile duct is extremely rare, so its clinico- pathological features and impact on the prognosis are not well known. To the best of our knowledge, only three cases of SRCC of the extrahepatic bile duct have been reported in the English literature.5-7 Herein, we present a case of SRCC originating from the epithelium of the distal extrahepatic bile duct.

CASE REPORT

A 63-year-old man presented with a 2-week history of epi- gastric pain and jaundice. His past medical history was unre- markable. Total bilirubin concentration was 9.3 mg/dL, alka- line phosphatase level was 290 IU/L (normal range, 115 to 359 IU/L), carcinoembryonic antigen was 1.1 ng/mL (normal range, 0 to 7 ng/mL), and cancer antigen 19-9 was 3.9 U/mL (normal range, 0 to 37 U/mL). Abdominal computed tomography (CT) showed wall thickening and luminal narrowing at the distal common bile duct (CBD) with proximal intrahepatic duct dila- tation (Fig. 1A). Gastroduodenal fiberscopy revealed normal gastric and duodenal mucosa except a prominent ampulla, and biopsy of the ampulla showed inflammatory change. Endoscop- ic retrograde cholangiogram showed complete obstruction due to polypoid mass at the distal CBD and preoperative endoscopic bile drainage was performed (Fig. 1B). Upon clinical implica- tion of carcinoma arising at the distal CBD, a pylorus-preserv- ing pancreatoduodenectomy was performed.

The surgically-removed specimen showed that the ulcerofun- gating tumor at the distal CBD with the size of 1.5 cm in diam- eter (Fig. 2A). A microscopic examination of the tumor revealed diffusely infiltrative tumor cells invading into the capsule of the pancreas (Fig. 2B). The tumor cells contained abundant intracy- toplasmic mucin, which pressed the nuclei toward the periphery of the tumor cells (Fig. 2C). Focal production of the mucin pool was identified, but it did not exceed 50% of the tumor. Some of the tumor cells consisted of poorly formed glandular structures, but even the tumor cells forming glands retained the same cyto- logic features with individually infiltrative signet-ring cells. At the interface between tumor and adjacent normal mucosa, no preneoplastic change was identified. Numerous lymphatic em- boli and a few foci of perineural invasion were observed (Fig. 2D). Lymph node metastasis was not present in any of the nine submitted lymph nodes and all resection margins were free of carcinoma. TNM staging of the tumor was pT3N0M0, stage IIA according to the seventh edition of the American Joint Committee on Cancer (AJCC) cancer staging system.

The patient's recovery was uneventful. The patient was regu- larly followed up. Five months after surgery, lymph node me- tastasis around the paraaortic area was found on abdominal CT, but the patient did not want to have chemotherapy. He died 15 months after surgery due to multiple distant metastases.

DISCUSSION

Several cases of SRCC originating from the biliary epitheli- um including the ampulla of Vater, gallbladder and intrahepat- ic bile duct have been reported,8,9 but SRCC of the extrahepatic bile duct is extremely unusual. To the best of our knowledge, only three cases of SRCC of the extrahepatic bile duct including two Japanese and one Korean patient have been reported in the English literature.5-7 Clinicopathologic features of reported SRCC cases arising in the extrahepatic bile duct are summa- rized in Table 1. Interestingly, all four patients were Asians, but their age and follow-up data were variable.

Because this type of variant is extremely rare in sites other than the stomach, SRCC of gastric origin should be excluded, once it is found in another site. In the present case, gastroduo- denal fiberscopy revealed no mucosal lesion in the stomach, du- odenum, or peri-ampullary region. Thus, it is unlikely that the tumor is a metastatic lesion.

Although periampullary tumors require the same surgical ap- proach, the prognosis of the tumor differs according to its origin. Tumors with a biliary epithelial origin are known to have a bet- ter prognosis than those with a duodenal or pancreatic ductal epithelial origin.10 Although the present case originated clearly from the bile duct, the patient developed lymph node metastasis around the paraaortic area at 5 months after surgery and died at 15 months after surgery. The poor prognosis may be related with presence of perineural invasion and lymphatic invasion. It is unclear whether the prognosis of SRCC of the extrahepatic bile duct is worse than that of ordinary type carcinoma at the same stage, because only rare cases of this variant have been re- ported. The impact of signet-ring cell type histology on the prognosis of extrahepatic bile duct carcinoma may be deter- mined through additional reports of this unusual variant.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

References

REFERENCES

1. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classifica- tion of tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010.

2. Kunisaki C, Shimada H, Nomura M, Matsuda G, Otsuka Y, Akiya- ma H. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br J Surg 2004; 91: 1319-24.

3. Otsuji E, Yamaguchi T, Sawai K, Takahashi T. Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 1998; 67: 216-20.

4. Malka D, Boige V, Dromain C, Debaere T, Pocard M, Ducreux M. Biliary tract neoplasms: update 2003. Curr Opin Oncol 2004; 16: 364-71.

5. Hiraki M, Yakushiji H, Hashiguchil K, et al. Signet ring cell carcino- ma of the lower bile duct with rapid growth: report of a case. Hepa- togastroenterology 2007; 54: 1922-4.

6. Ogata S, Kimura A, Hatsuse K, et al. Poorly differentiated adeno- carcinoma with signet-ring cell carcinoma of the extrahepatic bile duct in a 42-year-old Japanese female: a case report. Acta Med Okayama 2010; 64: 63-5.

7. Lee EY, Kim C, Kim MJ, et al. Signet ring cell carcinoma of the ex- trahepatic bile duct. Gut Liver 2010; 4: 402-6.

8. Li L, Chen QH, Sullivan JD, Breuer FU. Signet-ring cell carcinoma of the ampulla of Vater. Ann Clin Lab Sci 2004; 34: 471-5.

9. Yamauchi K, Ozeki Y, Sumi Y, Yamada T, Koyama H. A case of sig- net ring cell carcinoma of the gallbladder with anomalous pancre- aticobiliary ductal union. Nihon Shokakibyo Gakkai Zasshi 2000; 97: 204-8.

10. Dawson PJ, Connolly MM. Influence of site of origin and mucin production on survival in ampullary carcinoma. Ann Surg 1989; 210: 173-9.